Search Results - "Carr, Ryan Michael"

Association of human interpretable features derived from pancreatic ductal adenocarcinoma pathology slides with disease-free survival by Siddiqui, Zafar, Haemmerle, Robert, Carr, Ryan Michael

“…e16368 Background: Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second cause of cancer death in the US by 2040. For the minority of patients…”
Get full text

Molecular and clinical characteristics of patients with KRAS mutated pancreatic ductal adenocarcinoma by Xiao, Alexander Hua, Desai, Aakash, Halfdanarson, Thorvardur Ragnar, Alberts, Steven R, McWilliams, Robert R., Mahipal, Amit, Bekaii-Saab, Tanios S., Shi, Qian, Carr, Ryan Michael, Ma, Wen Wee

“…e16259 Background: Patients with KRAS mutant (mt) pancreatic ductal adenocarcinoma (PADC) have worse survival outcomes compared to KRAS wild-type (wt) PDAC…”
Get full text

Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer by McWilliams, Robert R., Kasi, Pashtoon Murtaza, Foster, Nathan R., Zhu, Mojun, Carr, Ryan Michael, Ma, Wen Wee, Hartgers, Mindy L., Jones, Kayla M., Bartusiewicz, Jacqueline M., Dong, Haidong, Markovic, Svetomir, Alberts, Steven R, Ahn, Daniel H., Babiker, Hani M., Bekaii-Saab, Tanios S., Couch, Fergus

“…TPS780 Background: Pancreatic adenocarcinoma is an aggressive malignancy with a limited number of therapeutic options. One subset of patients (up to 15%)…”
Get full text

Utilizing the Warburg Effect to Enhance TRAIL-Induced Apoptosis in Several Cancer Types by Carr, Ryan Michael

“…A study was conducted investigating the therapeutic potential of exploiting metabolic reprogramming of cancer cells for sensitization to an extrinsic mediator…”
Get full text